To boldly go—or to go too boldly? The accelerator hypothesis revisited E. A. M. Gale Editorial 20 June 2007 Pages: 1571 - 1575
Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiology J. S. Yudkin Review 26 June 2007 Pages: 1576 - 1586
Changing perspectives in diabetes: their impact on its classification T. J. Wilkin For debate 25 April 2007 Pages: 1587 - 1592
Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes J. HartwegA. J. FarmerH. A. W. Neil Meta-analysis 31 May 2007 Pages: 1593 - 1602
Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study J. M. BarkerK. K. McFannon behalf of DPT-1 Study Group Short Communication 22 June 2007 Pages: 1603 - 1606
Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromsø Study J. KronborgS. H. JohnsenT. Jenssen Article 09 June 2007 Pages: 1607 - 1614
Impact of the peroxisome proliferator activated receptor-γ coactivator-1β (PGC-1β) Ala203Pro polymorphism on in vivo metabolism, PGC-1β expression and fibre type composition in human skeletal muscle C. LingL. WegnerP. Poulsen Article 20 June 2007 Pages: 1615 - 1620
Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent S. C. ElbeinW. S. ChuP. A. Kern Article 20 June 2007 Pages: 1621 - 1630
Bivariate genome-wide scan for metabolic phenotypes in non-diabetic Chinese individuals from the Stanford, Asia and Pacific Program of Hypertension and Insulin Resistance Family Study Y.-F. ChiuL.-M. ChuangThe SAPPHIRe Study Group Article 20 June 2007 Pages: 1631 - 1640
Fatty liver and obesity: phenotypically correlated but genetically distinct traits in a mouse model of type 2 diabetes M. Itoi-BabayaH. IkegamiT. Ogihara Article 05 June 2007 Pages: 1641 - 1648
Dominant negative mutant forms of the cAMP response element binding protein induce apoptosis and decrease the anti-apoptotic action of growth factors in human islets S. A. SarkarJ. GunterS. Pugazhenthi Article 26 June 2007 Pages: 1649 - 1659
The c-Jun N-terminal kinase JNK participates in cytokine- and isolation stress-induced rat pancreatic islet apoptosis S. AbdelliA. AbderrahmaniC. Bonny Article 09 June 2007 Pages: 1660 - 1669
Single residue (K332A) substitution in Kir6.2 abolishes the stimulatory effect of long-chain acyl-CoA esters: indications for a long-chain acyl-CoA ester binding motif R. BränströmI. B. LeibigerP.-O. Berggren Article 24 May 2007 Pages: 1670 - 1677
Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1β and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells E. OetjenR. BlumeW. Knepel Article 22 June 2007 Pages: 1678 - 1687
Betacellulin inhibits amylase and glucagon production and promotes beta cell differentiation in mouse embryonic pancreas S. ThowfeequK. L. RalphsD. Tosh Article 12 June 2007 Pages: 1688 - 1697
Differential effects of fatness, fitness and physical activity energy expenditure on whole-body, liver and fat insulin sensitivity H. B. HoltS. H. WildC. D. Byrne Article 30 May 2007 Pages: 1698 - 1706
Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis T. McLaughlinA. ShermanS. W. Cushman Article 05 June 2007 Pages: 1707 - 1715
Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual N. FranckK. G. StenkulaF. H. Nystrom Article 16 June 2007 Pages: 1716 - 1722
Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus M. BajajS. SuraamornkulR. A. DeFronzo Article 23 May 2007 Pages: 1723 - 1731
Dilinoleoyl-phosphatidic acid mediates reduced IRS-1 tyrosine phosphorylation in rat skeletal muscle cells and mouse muscle R. CazzolliT. W. MitchellC. Schmitz-Peiffer Article 26 June 2007 Pages: 1732 - 1742
Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs L. J. HampsonP. MackinL. Agius Article 20 June 2007 Pages: 1743 - 1751
Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets V. A. GaultP. L. McCleanP. R. Flatt Article 09 June 2007 Pages: 1752 - 1762
Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume A. M. WesselsS. A. R. B. RomboutsF. J. Snoek Article Open access 02 June 2007 Pages: 1763 - 1769
Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties A. HoangA. J. MurphyD. Sviridov Article 20 June 2007 Pages: 1770 - 1779
The accelerator hypothesis cannot be tested using the type 2 diabetes gene, TCF7L2 T. J. Wilkin Letter 23 June 2007 Pages: 1780 - 1780
Comment on: Krabbe KS, Nielsen AR, Krogh-Madsen R et al (2007) Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50:431–438 G. N. ChaldakovA. B. TonchevL. Aloe Letter 02 June 2007 Pages: 1781 - 1782